Time trends in the incidence and causes of blindness in Israel

American Journal of Ophthalmology

Volumn 153, Issue 2, 2012, Pages

  Skaat, Alon ^a   Chetrit, Angela ^b   Belkin, Michael ^a   Kinori, Michael ^a   Kalter Leibovici, Ofra ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLINDNESS; CATARACT; CAUSAL ATTRIBUTION; CHILD; DIABETIC RETINOPATHY; FEMALE; GLAUCOMA; HUMAN; INCIDENCE; INFANT; ISRAEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGISTER; RETINA MACULA AGE RELATED DEGENERATION; RETROSPECTIVE STUDY; TREND STUDY;

EID: 84856023315     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2011.08.035     Document Type: Article

References (29)

1. S. Resnikoff, D. Pascolini, D. Etya'ale Global data on visual impairment in the year 2002 Bull World Health Organ 82 11 2004 844 851 (Pubitemid 39573742)
2. D. Pascolini, S.P. Mariotti, G.P. Pokharel 2002 global update of available data on visual impairment: a compilation of population-based prevalence studies Ophthalmic Epidemiol 11 2 2004 67 115 (Pubitemid 38530465)
3. K. Ahmad WHO programme gives hope to blind and partially sighted people in Africa Lancet 355 9214 2000 1528
4. M.D. Farber National Registry for the Blind in Israel: estimation of prevalence and incidence rates and causes of blindness Ophthalmic Epidemiol 10 4 2003 267 277 (Pubitemid 37041282)
5. Bunce C., Xing W., Wormald R. Causes of blind and partial sight certifications in England and Wales: April 2007March 2008. Eye (Lond);24(11):16921699.
6. C. Trautner, B. Haastert, B. Richter Incidence of blindness in southern Germany due to glaucoma and degenerative conditions Invest Ophthalmol Vis Sci 44 3 2003 1031 1034 (Pubitemid 36297817)
7. O'Colmain U., Anijeet D., Vosoughi M., et al. Glaucoma blind registration in Fife (20002009)a retrospective cohort study. Ophthalmic Physiol Opt;31(4):360366.
8. V.K. Yong, W.H. Morgan, R.L. Cooper Trends in registered blindness and its causes over 19 years in Western Australia Ophthalmic Epidemiol 13 1 2006 35 42 (Pubitemid 43336336)
9. The international conference for the tenth revision of the International Classification of Diseases Strengthening of Epidemiological and Statistical Services Unit World Health Organization, Geneva World Health Stat Q 43 4 1990 204 245
10. R. Avisar, I. Bahar, D. Weinberger Causes of blindness in the year 2000 in Israel Harefuah 142 2 2003 94 96 160
11. R. Avisar, R. Friling, M. Snir Estimation of prevalence and incidence rates and causes of blindness in Israel, 19982003 Isr Med Assoc J 8 12 2006 880 881 (Pubitemid 46017778)
12. A. Kvanta, P.V. Algvere, L. Berglin, S. Seregard Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor Invest Ophthalmol Vis Sci 37 9 1996 1929 1934 (Pubitemid 26324159)
13. Martin D.F., Maguire M.G., Ying G.S., et al. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med;364(20):18971908.
14. M.S. Ip, I.U. Scott, G.C. Brown Anti-vascular endothelial growth factor pharmacotherapy for age-related macular degeneration: a report by the American Academy of Ophthalmology Ophthalmology 115 10 2008 1837 1846
15. N. Ferrara, K.J. Hillan, H.P. Gerber, W. Novotny Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer Nat Rev Drug Discov 3 5 2004 391 400 (Pubitemid 38618122)
16. Tufail A., Patel P.J., Egan C., et al. Bevacizumab for neovascular age related macular degeneration (ABC Trial): multicentre randomised double masked study. BMJ;340:c2459.
17. Bressler N.M., Doan Q.V., Varma R., et al. Estimated cases of legal blindness and visual impairment avoided using ranibizumab for choroidal neovascularization: non-Hispanic white population in the United States with age-related macular degeneration. Arch Ophthalmol;129(6):709717.
18. I. Kaiserman, N. Kaiserman, S. Nakar, S. Vinker The effect of combination pharmacotherapy on the prescription trends of glaucoma medications J Glaucoma 14 2 2005 157 160 (Pubitemid 40389186)
19. N. Mansur, A. Weiss, A. Hoffman Continuity and adherence to long-term drug treatment by geriatric patients after hospital discharge: a prospective cohort study Drugs Aging 25 10 2008 861 870
20. T.Y. Wong, M. Mwamburi, R. Klein Rates of progression in diabetic retinopathy during different time periods: a systematic review and meta-analysis Diabetes Care 32 12 2009 2307 2313
21. S. Weitzman, S. Greenfield, J. Billimek Improving combined diabetes outcomes by adding a simple patient intervention to physician feedback: a cluster randomized trial Isr Med Assoc J 11 12 2009 719 724
22. A. Elis, L. Rosenmann, G. Chodick The association between glycemic, lipids and blood pressure control among Israeli diabetic patients QJM 101 4 2008 275 280 (Pubitemid 351426133)
23. S. Vinker, S. Nakar, R. Ram Quality of diabetes care in the community: a cross-sectional study in central Israel Isr Med Assoc J 7 10 2005 643 647 (Pubitemid 41489019)
24. E.Y. Chew, F.L. Ferris 3rd, K.G. Csaky The long-term effects of laser photocoagulation treatment in patients with diabetic retinopathy: the early treatment diabetic retinopathy follow-up study Ophthalmology 110 9 2003 1683 1689 (Pubitemid 37025423)
25. Witkin A.J., Brown G.C. Update on nonsurgical therapy for diabetic macular edema. Curr Opin Ophthalmol;22(3):185189.
26. G. Kleinmann, E. Asia Epidemiology of cataract surgeries in Israel: 2 decade review (19902009) Israel Journal of Eye Update 11 2010 30 32
27. M.B. Guerin, T.H. Flynn, J. Brady, J.O. Colm Worldwide geographical distribution of ophthalmology publications Int Ophthalmol 29 6 2008 511 516
28. O.E. Babalola, I.E. Murdoch, S. Cousens Blindness: how to assess numbers and causes? Br J Ophthalmol 87 3 2003 282 284 (Pubitemid 36307899)
29. S.A. Asleh, I. Chowers Ethnic background as a risk factor for advanced age-related macular degeneration in Israel Isr Med Assoc J 9 9 2007 656 658 (Pubitemid 47490961)